Click to Share
 

Stem Cell Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Blue Horizon International
Brian Mehling, M.D. and Marina Manvelyan, Ph.D., will attend a three-day long Masterclass in Clinical Trials and Medicine Development from February 22 - 24, 2017 in New York, NY.
12597527
By The Ohio State Univ. College of Engineering
Ohio State biomedical engineering professor's research team devises new approach for regenerative medicine treatment for heart attack
By Blue Horizon Therapeutic Sciences, LLC
BHI Therapeutic Sciences, LLC Announces Research, Development of New Product - BlueCellule™ - a Clinical Cell Therapy.
12464658
By Kansas Regenerative Medicine Center
Kansas Regenerative Medicine Center announces the addition of Steve Peloquin M.D. Dr. Peloquin is double board certified in Anesthesiology and Pain Management and specializes in neck and back health.
12455091
By SMi Group
With doors set to open next month to BioBanking 2015, SMi Group spoke to some of this years attendees to hear their thoughts about the 5th annual show in London
12453740
By SMi Group
The 5th annual Biobanking show will take place on 22nd & 23rd June 2015, London UK
By DCare and Meba UK
The latest in wound healing for chronic wound specifically for Diabetics
12429483
By Excitement Radio, Inc.
Erin Castillo is seeking stem-cell & chemotherapy via a procedure known as HSCT or hematopoietic stem cell treatment, in hopes to cure her Multiple Sclerosis, is interviewed by Angela Beasley of ExcitementRadio on GetChaMindRight Feb 26 at 7pm EST
By SMi Group
Advances in Cell Based Assays, 11th & 12th November 2014, London UK
12357094
By SMi Group
Advances in Cell Based Assays, 11th & 12th November 2014, Marriott Regents Park Hotel, London UK
12352106
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com Malcolm K. Brenner, MD, PhD Receives Pioneer Award for Advances in Gene-Modified T Cells Targeting Cancer New Rochelle, NY—Malcolm K.
12333438
By AnteAGE by Cellese
Up to 40% reduction in post-laser recovery time leads national U.S. laser distributor to recommend products in their company's post-procedure protocol. Anti-inflammatory effect aligns with recommendations of medical micro-needling guru.
12293379
By South Florida Bone Marrow Stem Cell Trans. Inst.
On March 8 2014, Dr. Dipnarine Maharaj delivered the keynote address for the Annie Appleseed conference in West Palm Beach, FL. The conference featured leading speakers from North America on common and alternative modalities for cancer treatment.
12270926
By Stem Cell Cryobank
The AABB has given the Stem Cell Cryobank, a leading cord blood, tissue, and adult stem cell bank, its accreditation for quality and safety for a 7th consecutive year.
By Blue Horizon International
Broadcaster Jimmy Johnson to Host Segments That Educate Public on Stem Cell Treatments
12238962
By Blue Horizon International
Blue Horizon Stem Cells unveiled their new Special Skin Serum on September 26 at Fashion Week in Paris, France.
By Bioheart, Inc.
Sheldon T. Anderson has been elected to the Board of Directors of Bioheart, Inc.
By Stemedix, Inc.
Stemedix™ (stemedix.com), a Florida based Autologous Adipose Stem Cell treatment group is offering its Stem Cell therapy and expertise to patients with degenerative diseases all over the world.
By OZ Biosciences
OZ Biosciences SAS, specialized in the development of innovative transfection technologies is delighted to announce the launching of new mRNA transfection Reagents : RmesFect™ and RmesFect™ Stem.
By allcells
AllCells is excited to announce the launch of our new mobilized peripheral blood products including two types of CD34+ cells mobilizing agents: Granulocyte-Colony Stimulating Factor (G-CSF, Neupogen®) and Plerixafor (Mozobil®) through IRB approved...

All Press Releases

By TD The Market Publishers, Ltd.
The global market for stem cell therapies is predicted to keep on growing at a healthy rate through 2021, according to new report by MarketsandMarkets available at MarketPublishers.com.
By Blue Horizon International
Brian Mehling, M.D. and Marina Manvelyan, Ph.D., will attend a three-day long Masterclass in Clinical Trials and Medicine Development from February 22 - 24, 2017 in New York, NY.
12597527
By The Ohio State Univ. College of Engineering
Ohio State biomedical engineering professor's research team devises new approach for regenerative medicine treatment for heart attack
By Biotech Support Group
Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for improving the proteomic information obtained from bronchoalveolar lavage fluid (BALF).
By American Academy of Neurology
A phase II clinical trial in people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, suggests that transplanting human stem cells into the spinal cord may be done safely.
By DelveInsight Business Research
DelveInsight, the leading market research and consulting company has added new report Stem Cell Oncology –Pipeline Insights, 2016 to its portfolio. With this launch, DelveInsight now has 700+ Reports on Indication Pipeline Insight.
By Cryoviva Biotech Private Limited
Cryoviva Biotech Private Limited aims to take forward the good work done by Cryobanks International India Pvt. Ltd. This will lead Cryoviva towards higher parameters of services with authenticity and trusted words.
By Americans for Cures Foundation
How California became the center of the stem cell universe - and why that matters to you!
By Blue Horizon Therapeutic Sciences, LLC
BHI Therapeutic Sciences, LLC Announces Research, Development of New Product - BlueCellule™ - a Clinical Cell Therapy.
By GeneTex
GeneTex proudly offers an excellent Nanog antibody to assist your embryonic stem cell research.
By GeneTex
Don’t run out of Runx2 antibody! GeneTex's Runx2 is well validated and ready to help accelerate your research!
12464658
By Kansas Regenerative Medicine Center
Kansas Regenerative Medicine Center announces the addition of Steve Peloquin M.D. Dr. Peloquin is double board certified in Anesthesiology and Pain Management and specializes in neck and back health.
12455091
By SMi Group
With doors set to open next month to BioBanking 2015, SMi Group spoke to some of this years attendees to hear their thoughts about the 5th annual show in London
12453740
By SMi Group
The 5th annual Biobanking show will take place on 22nd & 23rd June 2015, London UK
By SMi Group Ltd
SMi’s BioBanking conference will be taking place on the 22 - 23 June 2015 at the Holiday Inn Regents Park Hotel in London, UK.
By SMi Group
Biobanking 2015 takes place on 22nd & 23rd June at the Holiday Inn Regents Park Hotel in London, UK
By DCare and Meba UK
The latest in wound healing for chronic wound specifically for Diabetics
By American Association of Anatomists
Transformative research in the field of cell biology, neuroanatomy, and anatomical science
By Visiongain
LONDON, UK, 3rd of February 2015: A new report by visiongain calculates that the global translational regenerative medicine market will reach $4.8bn in 2015 with revenues showing growth to 2025.
12429483
By Excitement Radio, Inc.
Erin Castillo is seeking stem-cell & chemotherapy via a procedure known as HSCT or hematopoietic stem cell treatment, in hopes to cure her Multiple Sclerosis, is interviewed by Angela Beasley of ExcitementRadio on GetChaMindRight Feb 26 at 7pm EST
By SMi Group
Advances in Cell Based Assays, 11th & 12th November 2014, London UK
By Rejuv Medical Minnesota
Rejuv Medical has led the stem cell industry in innovation and application of procedure. Now, the forward-thinking company is commenting on what seems to be a media blitz after the announcement of Robin Williams’ Parkinson's Disease Diagnosis.
12357094
By SMi Group
Advances in Cell Based Assays, 11th & 12th November 2014, Marriott Regents Park Hotel, London UK
12352106
By Mary Ann Liebert, Inc., publishers
Contact: Kathryn Ruehle, Mary Ann Liebert, Inc., (914) 740-2100, kruehle@liebertpub.com Malcolm K. Brenner, MD, PhD Receives Pioneer Award for Advances in Gene-Modified T Cells Targeting Cancer New Rochelle, NY—Malcolm K.
By tebu-bio, Stemgent-Asterand
Stemgent-Asterand (http://www.stemgent.com), an innovative provider of  cellular reprogramming reagents and iPS cell reprogramming services, and tebu-bio (http://www.tebu-bio.com) are pleased to announce their new sales and marketing agreement...
12333438
By AnteAGE by Cellese
Up to 40% reduction in post-laser recovery time leads national U.S. laser distributor to recommend products in their company's post-procedure protocol. Anti-inflammatory effect aligns with recommendations of medical micro-needling guru.
12293379
By South Florida Bone Marrow Stem Cell Trans. Inst.
On March 8 2014, Dr. Dipnarine Maharaj delivered the keynote address for the Annie Appleseed conference in West Palm Beach, FL. The conference featured leading speakers from North America on common and alternative modalities for cancer treatment.
12270926
By Stem Cell Cryobank
The AABB has given the Stem Cell Cryobank, a leading cord blood, tissue, and adult stem cell bank, its accreditation for quality and safety for a 7th consecutive year.
By Alzheimer's Disease Resource Center, Inc.
Bay Shore, NY — On Sunday, January 12th from 1:00 p.m. to 3:00 p.m. the Alzheimer’s Disease Resource Center will present What You Need to Know About Alzheimer’s at the Jewish Center of the Hamptons, located at 44 Woods Lane in East Hampton, NY. Ms.
By Blue Horizon International
Broadcaster Jimmy Johnson to Host Segments That Educate Public on Stem Cell Treatments

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share